CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 518	$ 564
Restricted cash	13	27
Trade receivables, net	1,688	1,790
Inventories, net	1,222	1,090
Prepaid expenses and other current assets	796	776
Total current assets	4,237	4,247
Property, plant and equipment, net	1,596	1,600
Intangible assets, net	5,552	5,800
Goodwill	11,579	11,547
Deferred tax assets, net	2,163	2,166
Other non-current assets	318	326
Total assets	25,445	25,686
Current liabilities:
Accounts payable	561	521
Accrued and other current liabilities	2,916	2,988
Current portion of long-term debt	446	432
Total current liabilities	3,923	3,941
Acquisition-related contingent consideration	219	208
Non-current portion of long-term debt	20,207	20,334
Deferred tax liabilities, net	205	202
Other non-current liabilities	746	741
Total liabilities	25,300	25,426
Commitments and contingencies (Note 18)
Equity (Deficit)
Common shares, no par value, unlimited shares authorized, 363,607,062 and 361,898,846 issued and outstanding at March 31, 2023 and December 31, 2022, respectively	10,405	10,391
Additional paid-in capital	171	159
Accumulated deficit	(9,387)	(9,186)
Accumulated other comprehensive loss	(1,989)	(2,056)
Total Bausch Health Companies Inc. shareholders’ deficit	(800)	(692)
Noncontrolling interest	945	952
Total equity	145	260
Total liabilities and equity	$ 25,445	$ 25,686